Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 30, 2016
Hematopoietic Cell Transplantation Comorbidity Index Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34<sup>+</sup> Selected Grafts for Allogeneic Hematopoietic Cell Transplantation
Pere Barba, Ravin Ratan, Christina Cho, et al.
Cancer
|
August 28, 2024
Moderately hypofractionated, preoperative radiotherapy in patients with soft tissue sarcomas (HYPORT-STS): Updated local control, late toxicities, and patient-reported outcomes
Andrew J Bishop, Devarati Mitra, Ahsan Farooqi, et al.
The Lancet. Oncology
|
November 7, 2022
Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial
B Ashleigh Guadagnolo, Roland L Bassett, Devarati Mitra, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 18, 2012
T cell-depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: long-term survival for patients in first complete remission with a decreased risk of graft-versus-host disease
Jenna D Goldberg, Alex Linker, Deborah Kuk, et al.
The Lancet. Oncology
|
October 9, 2020
Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study
Mrinal Gounder, Patrick Schöffski, Robin L Jones, et al.
Biorxiv : the Preprint Server for Biology
|
June 5, 2026
Spatially-Resolved Multiomic Atlas of Leiomyosarcoma Identifies Two Clinically Relevant Epigenetically-Driven Cell States
Ryan A Denu, Zhao Zheng, Yingda Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 18, 2022
Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study
Michael J Nathenson, Junxiao Hu, Ravin Ratan, et al.
Frontiers in Immunology
|
May 15, 2025
Dedifferentiated liposarcomas treated with immune checkpoint blockade: the MD Anderson experience
Madeline B Torres, Cheuk Hong Leung, Marianne Zoghbi, et al.
Cancers
|
July 8, 2020
IGF-1R/mTOR Targeted Therapy for Ewing Sarcoma: A Meta-Analysis of Five IGF-1R-Related Trials Matched to Proteomic and Radiologic Predictive Biomarkers
Hesham M Amin, Ajaykumar C Morani, Najat C Daw, et al.
Nature Communications
|
June 1, 2022
The androgen receptor is a therapeutic target in desmoplastic small round cell sarcoma
Salah-Eddine Lamhamedi-Cherradi, Mayinuer Maitituoheti, Brian A Menegaz, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 30, 2016
Hematopoietic Cell Transplantation Comorbidity Index Predicts Outcomes in Patients with Acute Myeloid Leukemia and Myelodysplastic Syndromes Receiving CD34<sup>+</sup> Selected Grafts for Allogeneic Hematopoietic Cell Transplantation
Pere Barba, Ravin Ratan, Christina Cho, et al.
Cancer
|
August 28, 2024
Moderately hypofractionated, preoperative radiotherapy in patients with soft tissue sarcomas (HYPORT-STS): Updated local control, late toxicities, and patient-reported outcomes
Andrew J Bishop, Devarati Mitra, Ahsan Farooqi, et al.
The Lancet. Oncology
|
November 7, 2022
Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial
B Ashleigh Guadagnolo, Roland L Bassett, Devarati Mitra, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 18, 2012
T cell-depleted stem cell transplantation for adults with high-risk acute lymphoblastic leukemia: long-term survival for patients in first complete remission with a decreased risk of graft-versus-host disease
Jenna D Goldberg, Alex Linker, Deborah Kuk, et al.
The Lancet. Oncology
|
October 9, 2020
Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study
Mrinal Gounder, Patrick Schöffski, Robin L Jones, et al.
Biorxiv : the Preprint Server for Biology
|
June 5, 2026
Spatially-Resolved Multiomic Atlas of Leiomyosarcoma Identifies Two Clinically Relevant Epigenetically-Driven Cell States
Ryan A Denu, Zhao Zheng, Yingda Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 18, 2022
Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study
Michael J Nathenson, Junxiao Hu, Ravin Ratan, et al.
Frontiers in Immunology
|
May 15, 2025
Dedifferentiated liposarcomas treated with immune checkpoint blockade: the MD Anderson experience
Madeline B Torres, Cheuk Hong Leung, Marianne Zoghbi, et al.
Cancers
|
July 8, 2020
IGF-1R/mTOR Targeted Therapy for Ewing Sarcoma: A Meta-Analysis of Five IGF-1R-Related Trials Matched to Proteomic and Radiologic Predictive Biomarkers
Hesham M Amin, Ajaykumar C Morani, Najat C Daw, et al.
Nature Communications
|
June 1, 2022
The androgen receptor is a therapeutic target in desmoplastic small round cell sarcoma
Salah-Eddine Lamhamedi-Cherradi, Mayinuer Maitituoheti, Brian A Menegaz, et al.
Page
of 6